VBI Vaccines Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was USD 0.346 million compared to USD 0.142 million a year ago. Net loss was USD 45.7 million compared to USD 17.48 million a year ago. Basic loss per share from continuing operations was USD 5.4 compared to USD 2.1 a year ago.
For the six months, sales was USD 0.472 million compared to USD 0.443 million a year ago. Net loss was USD 66.95 million compared to USD 35.12 million a year ago. Basic loss per share from continuing operations was USD 7.8 compared to USD 4.2 a year ago.